Creates a framework for the President, working with the U.S. Trade Representative, to negotiate “trusted trade partner” agreements with foreign governments to secure, diversify, and speed delivery of medical goods. The agreements can include commitments on manufacturing, regulatory alignment, information‑sharing, tariff/duty treatment, and supply‑chain transparency; Congress gets advance notice, a time‑bound review and the ability to block agreements; the USTR must monitor partner compliance and the President must act quickly on reported violations.